CVS Health (CVS) return on equity (ROE)

Return on equity · fiscal 2025
2.4%

CVS Health (CVS) earned a return on equity of 2.4% in fiscal 2025 (the year ended December 31, 2025). That is 3.8 percentage points lower than the 6.1% of fiscal 2024. Figures as of 17 Nov 2026, 21:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
2.4%
Change on fiscal 2024
−3.8 pts
Highest on record
17.6%fiscal 2017
Lowest on record
-1.0%fiscal 2018
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

CVS Health return on equity (ROE), in more detail

Across the 19 fiscal years on record (2007–2025), the highest was 17.6% in fiscal 2017 and the lowest -1.0% in fiscal 2018. The fiscal 2025 figure is higher than in 6% of the 18 earlier fiscal years on record, whose median is 10.3%.

History · 19 fiscal years

Return on equity by fiscal year

CVS Health return on equity (ROE), year by year

CVS Health (CVS) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
20252.4% 3.8 pts down
20246.1% 4.8 pts down
202310.9% 4.9 pts up
20226.0% 4.6 pts down
202110.7% 0.3 pts up
202010.3% 0.0 pts
201910.4% 11.4 pts up
2018-1.0% 18.6 pts down
201717.6% 3.1 pts up
201614.4% 0.4 pts up
201514.1% 1.8 pts up
201412.2% 0.1 pts up
201312.1% 1.8 pts up
201210.3% 1.2 pts up
20119.1% 0.0 pts
20109.1% 1.2 pts down
200910.3% 1.1 pts up
20089.2% 0.8 pts up
20078.4%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of CVS Health and comparable companies
CompanyReturn on equityFiscal year
McKesson MCK17.7%2020
Sanofi SNY10.9%2025
Moderna MRNA-32.6%2025
CVS Health CVS2.4%2025
HCA Healthcare HCA656.3%2020
GSK GSK34.9%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CVS

CVS Health, figure by figure

CVS Health (CVS) overview: price, valuation and scorecardAll health care companies by market value

CVS Health return on equity (ROE): questions and answers

What is CVS Health's return on equity?

CVS Health (CVS) earned a return on equity of 2.4% in fiscal 2025 (the year ended December 31, 2025). That is 3.8 percentage points lower than the 6.1% of fiscal 2024.

Is CVS Health's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 6% of the 18 earlier fiscal years on record, whose median is 10.3%.

What are the highest and lowest return on equity figures on record for CVS Health?

Across the 19 fiscal years on record (2007–2025), the highest was 17.6% in fiscal 2017 and the lowest -1.0% in fiscal 2018.

How is CVS Health's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CVS Health (CVS) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/CVS/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.